Pharmaceutical startups looking for seed funding to turn their ideas into reality and develop solutions that improve patients’ lives benefit greatly from early-stage capital. Such capital would be spent on innovation, breakthroughs in drug discovery, AI-related health technologies, and personalised medicine. For example, the majority of India’s healthcare startups are focused on creating tech solutions that drive efficiency in the supply chain or improve patient outcomes. These startups have utilised seed funding to enhance their offerings, streamline operations, and deliver better healthcare solutions.
Seed funding plays a pivotal role in this growth trajectory, serving as the essential capital that ignites innovation and propels startups forward. For many emerging companies, access to early-stage capital is crucial for developing their proof of concept (POC) and attracting top talent. In a highly competitive market, having the right resources enables startups to innovate rapidly and respond to the evolving needs of the healthcare sector. As artificial intelligence (AI) and other advanced technologies reshape the healthcare industry, startups face constant pressure to adapt and enhance their offerings. This necessity for continuous innovation underscores the importance of securing seed funding, as it allows companies to invest in research and development (R&D), refine their technologies, and launch new products or services without the immediate burden of achieving profitability.
Beginning of Innovation
This story is from the BioSpectrum India Nov 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum India Nov 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Key Skills & Salary Trends in Healthcare & Pharma for 2025
India’s healthcare and pharmaceutical sectors have witnessed tremendous growth in the last decade, with cutting-edge technology being widely integrated into operations.
"The pharma packaging landscape is evolving rapidly, driven by advancements in technology and changing regulatory landscapes"
Recently elevated from CEO to Chairman and Managing Director (CMD) of Ecobliss India, AVPS Chakravarthi, has been at the forefront of developing eco-friendly packaging technologies, particularly for the pharma, biotechnology and allied industries, worldwide.
"India needs vaccines that are 'Made for India"
With a legacy of over 75 years in pioneering advancements with their vaccines within the Indian pharmaceutical landscape, Mumbai-based Novo Medi Sciences (Novo Group) has been instrumental in introducing many first-of-itskind vaccines in India, playing a vital role in public health and setting standards in healthcare quality and accessibility.
"A 'no-strings-attached' funding model from industry may go a long way in strengthening India's innovation landscape"
The Infosys Prize 2024 in Life Sciences has been awarded to Siddhesh been awarded to Siddhesh Kamat, Associate Professor in the Department of Biology at the Indian Institute of Science Education and Research (IISER), Pune, for his discoveries concerning bioactive lipids and their receptors, and their metabolic and signalling pathways.
"We are focusing on developing 10 'Pharma Villages' to decentralise pharma production, taking manufacturing closer to rural areas"
With the Revanth Reddy led Telangana government completing its first year in office, Jayesh Ranjan, Principal Secretary of the Department of IT and Industries, shares his optimism about Telangana's future as a vibrant industrial hub.
